Literature DB >> 30217565

Context-dependent functions of KLF4 in cancers: Could alternative splicing isoforms be the key?

Liang Wang1, Feng Shen2, John R Stroehlein1, Daoyan Wei3.   

Abstract

Krüppel-like factor 4 (KLF4) is an important transcription factor that is expressed in a variety of tissues and regulates many critical physiologic and cellular processes, including cell proliferation, differentiation, stem cell reprogramming, maintenance of genomic stability, and normal tissue homeostasis. KLF4 has both tumor suppressive and oncogenic functions in gastrointestinal and other cancers. These functions are thought to be context dependent, but how KLF4 exerts these differential functions and the molecular mechanisms behind them remain poorly understood. Recent studies have shown that the KLF4 gene undergoes alternative splicing, and the protein products of certain transcripts antagonize wild-type KLF4 function, suggesting an additional layer of regulation of KLF4 function. Therefore, detailed study of KLF4 alternative splicing may not only provide new insights into the complexity of KLF4 functions but also lead to rational targeting of KLF4 for cancer prevention and therapy. Published by Elsevier B.V.

Entities:  

Keywords:  Alternative splicing; Cancer; Context-dependent function; KLF4

Mesh:

Substances:

Year:  2018        PMID: 30217565     DOI: 10.1016/j.canlet.2018.09.005

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  6 in total

1.  Knockdown of SNHG14 Alleviates MPP+-Induced Injury in the Cell Model of Parkinson's Disease by Targeting the miR-214-3p/KLF4 Axis.

Authors:  Shufang Zhou; Dan Zhang; Junnan Guo; Junshi Zhang; Yong Chen
Journal:  Front Neurosci       Date:  2020-09-21       Impact factor: 4.677

Review 2.  Recent Discoveries on the Involvement of Krüppel-Like Factor 4 in the Most Common Cancer Types.

Authors:  Agnieszka Taracha-Wisniewska; Grzegorz Kotarba; Sebastian Dworkin; Tomasz Wilanowski
Journal:  Int J Mol Sci       Date:  2020-11-22       Impact factor: 5.923

3.  DUB3/KLF4 combats tumor growth and chemoresistance in hepatocellular carcinoma.

Authors:  Xuebing Jia; Lei Li; Fan Wang; Ying Xue; Tongde Wu; Qianqian Jia; Yunhui Li; Chenming Wu; Yuping Chen; Jinhuan Wu; Yang Su; Xinshu Wang; Tao Zhuang; Xiao Dong; Jing Ling; Jian Yuan; Qi Li
Journal:  Cell Death Discov       Date:  2022-04-05

4.  Involvement of Cancer Stem Cells in Chemoresistant Relapse of Epithelial Ovarian Cancer Identified by Transcriptome Analysis.

Authors:  Yaoqi Sun; Lin Yao; Chunyan Wang; Bing Xiong; Jing Guo; Lian Wang; Jihui Zhu; Zhongping Cheng; Shupeng Liu
Journal:  J Oncol       Date:  2022-03-31       Impact factor: 4.375

5.  Exploring the Significance of the Exon 4-Skipping Isoform of the ZNF217 Oncogene in Breast Cancer.

Authors:  Aurélie Bellanger; Diep T Le; Julie Vendrell; Anne Wierinckx; Lőrinc S Pongor; Jérôme Solassol; Joël Lachuer; Philippe Clezardin; Balázs Győrffy; Pascale A Cohen
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244

6.  A Systematic Way to Infer the Regulation Relations of miRNAs on Target Genes and Critical miRNAs in Cancers.

Authors:  Peng Xu; Qian Wu; Jian Yu; Yongsheng Rao; Zheng Kou; Gang Fang; Xiaolong Shi; Wenbin Liu; Henry Han
Journal:  Front Genet       Date:  2020-03-31       Impact factor: 4.599

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.